title: Rosiglitazone and the case for safety over certainty.
authors.forename: David N
authors.initials: DN
authors.lastname: Juurlink
mesh_terms: D003657:Decision Making; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000401:mortality; D006333:Heart Failure / Q000453:epidemiology*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000453:epidemiology*; D000077205:Pioglitazone; D012306:Risk; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone